These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35326724)

  • 1. A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma.
    Yuan M; Shong K; Li X; Ashraf S; Shi M; Kim W; Nielsen J; Turkez H; Shoaie S; Uhlen M; Zhang C; Mardinoglu A
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach.
    Li X; Shong K; Kim W; Yuan M; Yang H; Sato Y; Kume H; Ogawa S; Turkez H; Shoaie S; Boren J; Nielsen J; Uhlen M; Zhang C; Mardinoglu A
    EBioMedicine; 2022 Apr; 78():103963. PubMed ID: 35339898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying prognostic features by bottom-up approach and correlating to drug repositioning.
    Li W; Yu J; Lian B; Sun H; Li J; Zhang M; Li L; Li Y; Liu Q; Xie L
    PLoS One; 2015; 10(3):e0118672. PubMed ID: 25738841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
    Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
    BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic protein interaction modules in human hepatocellular carcinoma progression.
    Yu H; Lin CC; Li YY; Zhao Z
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S2. PubMed ID: 24564909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network neighborhood operates as a drug repositioning method for cancer treatment.
    Cüvitoğlu A; Isik Z
    PeerJ; 2023; 11():e15624. PubMed ID: 37456868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of comprehensive bioinformatics approaches to reconnoiter crucial genes and pathways underpinning hepatocellular carcinoma: a drug repurposing endeavor.
    Nair G; Hema Sree GNS; Saraswathy GR; Marise VLP; Krishna Murthy TP
    Med Oncol; 2021 Oct; 38(12):145. PubMed ID: 34687371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predict New Therapeutic Drugs for Hepatocellular Carcinoma Based on Gene Mutation and Expression.
    Yu L; Xu F; Gao L
    Front Bioeng Biotechnol; 2020; 8():8. PubMed ID: 32047745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer.
    Beklen H; Gulfidan G; Arga KY; Mardinoglu A; Turanli B
    Front Oncol; 2020; 10():1273. PubMed ID: 32903699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Integrated System Biology Approach Yields Drug Repositioning Candidates for the Treatment of Heart Failure.
    Yang G; Ma A; Qin ZS
    Front Genet; 2019; 10():916. PubMed ID: 31608126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma.
    Zou RC; Liang Y; Li LL; Tang JZ; Yang YP; Geng YC; He J; Luo LY; Li WX; Sun ZW; Yuan HL
    Med Sci Monit; 2019 Nov; 25():8618-8627. PubMed ID: 31730575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug repositioning in head and neck squamous cell carcinoma: An integrated pathway analysis based on connectivity map and differential gene expression.
    Wei GG; Gao L; Tang ZY; Lin P; Liang LB; Zeng JJ; Chen G; Zhang LC
    Pathol Res Pract; 2019 Jun; 215(6):152378. PubMed ID: 30871913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.
    Tan F; Yang R; Xu X; Chen X; Wang Y; Ma H; Liu X; Wu X; Chen Y; Liu L; Jia X
    Mol Biosyst; 2014 May; 10(5):1126-38. PubMed ID: 24603772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 16. Prediction of Novel Drugs for Hepatocellular Carcinoma Based on Multi-Source Random Walk.
    Yu L; Su R; Wang B; Zhang L; Zou Y; Zhang J; Gao L
    IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(4):966-977. PubMed ID: 27076463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MD-Miner: a network-based approach for personalized drug repositioning.
    Wu H; Miller E; Wijegunawardana D; Regan K; Payne PRO; Li F
    BMC Syst Biol; 2017 Oct; 11(Suppl 5):86. PubMed ID: 28984195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer's Disease.
    Lee SY; Song MY; Kim D; Park C; Park DK; Kim DG; Yoo JS; Kim YH
    Front Pharmacol; 2019; 10():1653. PubMed ID: 32063857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
    Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
    BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug repositioning based on network-specific core genes identifies potential drugs for the treatment of autism spectrum disorder in children.
    Gao H; Ni Y; Mo X; Li D; Teng S; Huang Q; Huang S; Liu G; Zhang S; Tang Y; Lu L; Liang H
    Comput Struct Biotechnol J; 2021; 19():3908-3921. PubMed ID: 34306572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.